Alphabetical listing of all products

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Prices
  • 5 mg - 52 EUR
  • 25 mg - 208 EUR
  • 100 mg - 624 EUR

Canertinib

Canertinib is an orally available irreversible inhibitor of receptor tyrosine kinases that targets EGFRs. It has IC50 values of 0.8, 19 and 7 nM for EGFR, HER-2 and ErbB-4, respectively. Canertinib was beány developed as an anticancer drug, but its development was discontinued.

catalogue number: C098
synonyms: CI-1033, PD-183805
CAS: 267243-28-7
MW: 485.94 g/mol

References
J Med Chem. 2000 Apr 6;43(7):1380-97. PMID: 10753475
IDrugs. 2004 Jan;7(1):58-63. PMID: 14730468